HbA1C and Haemoglobin Variant Analysers
A Contract Award Notice
by UNIVERSITY HOSPITALS PLYMOUTH NHS TRUST
- Source
- OJEU
- Type
- Contract (Supply)
- Duration
- 7 year (est.)
- Value
- £1M
- Sector
- INDUSTRIAL
- Published
- 26 Feb 2021
- Delivery
- To 26 Feb 2028 (est.)
- Deadline
- n/a
Concepts
Location
Trusts within the boundaries of NHS South West
2 buyers
1 supplier
- Sebia Surrey
Description
HbA1C and Haemoglobin Variant Analysers and Associated Consumables and Reagents.
Total Quantity or Scope
The requirement is for a fully automated analytical platform capable of rapidly and accurately performing Haemoglobin A1C and haemoglobin variant measurements for Diabetes' screening and monitoring, Antenatal Haemoglobinpathy screening and Haemoglobin variant detection. The contract will be 5 years with an option to extend for a further 2 years. The contract value is estimated around £1.5million in total for the Trusts involved. It is the intention of the Trusts to novate the award of this contract into the Pathology Managed Laboratory Service contracts in this region, currently with Roche Diagnostics Ltd and Abbott Laboratories Ltd. By responding to the tender you are confirming your acceptance for the awarded contract to be novated.
Award Detail
1 | Sebia (Surrey)
|
Award Criteria
PRICE | _ |
CPV Codes
- 38434520 - Blood analysers
- 33124100 - Diagnostic devices
- 38000000 - Laboratory, optical and precision equipments (excl. glasses)
- 85111800 - Pathology services
- 85111810 - Blood analysis services
Indicators
- Award on basis of price.
Reference
- OJEU 101462-2021